Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma.

Sharma, Rohini; Koruth, Roy; Kanters, Steve; Druyts, Eric; Tarhini, Ahmad.
J Comp Eff Res; 8(16): 1349-1363, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31778073